@mayapath2health
As we know, it’s important to follow up with an antiresorptive therapy to help preserve (or “lock in”) the bone gains after Evenity. From what I’ve gathered, there are two scenarios to consider:

Treatment target reached - based on BMD improvements, T-score, and FRAX score. Options include:
• Reclast or other antiresorptives, depending on preference;
• Short-term (1–2 yrs) Prolia followed by Reclast. Some endos do this, as Prolia may further improve BMD per clinical studies;
• Long-term Prolia: requires ongoing commitment; stopping abruptly carries a risk of rebound bone loss

When treatment target not reached or fracture risk remains high:
Another round of anabolic therapy may be considered. This is trickier, as clinical data are limited. Some go directly from one anabolic to another; others use a bridging agent. I think @255anny may fall into this category.

To make the best choice, you’d ideally need a DEXA scan now (after Evenity) to guide your next step imo.